Category: SMID Cap Growth Commentaries

U.S. equity markets shook off the brief “banking crisis” and a lackluster earnings reporting period to continue their march toward recovery, ending the half closing in on early 2022 highs with growth stocks outperforming in both large and small caps. This positive development unfolded as each subsequent month’s macro-economic data reports showed the rate of…

As anticipated entering the year, macro-economic news continues to dominate the headlines and is driving a high level of equity market volatility. The year started off strong, extending the rebound that started in Q4 . . . until the strains from the record pace of interest rate increases finally caused something to “break”: two regional…

While Q4 provided a welcome reprieve and possibly the first indication that we can begin to look forward to a market backdrop that is more constructive for individual stock-selection, as a whole 2022 was a disappointing year for investors, particularly those investing in growth-oriented strategies.  Excessive inflation was the main culprit – a result of…

Quarter Summary: It was another difficult (and volatile) quarter for U.S. equity market returns, driven by macro factors as the peak and duration of higher interest rates continued to be debated and absorbed into both valuations and future earnings expectations. Broad inflation measures (CPI/PPI) continued to come in hot and the Federal Reserve aggressively increased…